Inside the Lab: Building Histology Capabilities for Modern Clinical Trials – Q&A with Rob McGee, MD, PhD
When I joined, Medpace was expanding its histology and anatomic pathology services in response to growing Sponsor demand. What attracted...
Raising the Standard in Pediatric Migraine Clinical Trials
Featuring: Dr. Sonia Quintas, MD, MSc, Theresa Veira, MSN, MBA, and Pora Kuperman, MPH, PhD Migraine is a leading cause...
Key Highlights from Digestive Disease Week 2026
Digestive Disease Week® 2026 reinforced its position as one of the leading global forums in gastroenterology, bringing together clinicians, researchers,...
Q&A With New Medical Expert: Dr. Jack Bleesing, MD, PhD
Medpace is proud to welcome Dr. Jack Bleesing, an accomplished immunologist and board-certified physician-scientist, with 20+ years of experience to...
ASN Kidney Week: Transformative Nephrology Insights
In this blog, Dr. Ajay Srivastava, Vice President, Medical Department, reflects on these key takeaways from 2025 ASN Kidney Week...
What’s Next for ID&V? Clinical Development Trends from ESCMID Global 2026
Explore several of the key themes emerging from ESCMID Global 2026.
Advancing Psychiatry Clinical Development Through Science, Precision, and Human-Centered Design
Mental health disorders affect an estimated one billion people worldwide, contributing to profound personal, social, and economic burden. As the World Health Organization notes, most…
Inside the Lab: Advancing Flow Cytometry in Clinical Trials – Q&A with Andre Olsson, PhD
I was interested in expanding my horizons beyond basic research and developing my knowledge in applied flow cytometry research. I...
Inside AD/PD 2026: Emerging Breakthroughs in Alzheimer’s and Parkinson’s
Authors: Carmen Gasca-Salas, MD, MSc, PhD, Medical Director, Medpace Recently, the Medpace neuroscience team attended the AD/PD (Alzheimer’s & Parkinson’s Disease)...
Expert Insights: How Targeted Protein Degraders are Advancing Oncology Drug Development with Dr. Blythe Thomson
As a Hematologist/Oncologist, I have always been a life-long advocate of the rigor and structure of a clinical trial. That...